US7504911022 - Common Stock
RADNET INC
NASDAQ:RDNT (12/6/2024, 8:10:52 PM)
After market: 81.61 0 (0%)81.61
+2.45 (+3.09%)
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 7,872 full-time employees. The company went IPO on 2001-12-12. The company has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.
RADNET INC
1510 Cotner Ave
Los Angeles CALIFORNIA 90025
P: 13104787808
CEO: Howard G. Berger
Employees: 7872
Website: https://www.radnet.com/
/PRNewswire/ -- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc....
LOS ANGELES, Dec. 02, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...
At RSNA 2024, DeepHealth launches new AI-powered informatics and SmartTechnology™ solutions powered by DeepHealth OS, its pioneering cloud-native operating...
Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operational...
DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation...
SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection. The clearance enables...
Here you can normally see the latest stock twits on RDNT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: